Dr. John Brandsema, MD
NPI: 1275889792
Total Payments
$675,648
2024 Payments
$47,440
Companies
21
Transactions
839
Medicare Patients
47
Medicare Billing
$1,906
Payment Breakdown by Category
Other$276,953 (41.0%)
Consulting$264,603 (39.2%)
Travel$97,455 (14.4%)
Food & Beverage$18,980 (2.8%)
Research$16,857 (2.5%)
Education$800.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $264,603 | 75 | 39.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $237,033 | 80 | 35.1% |
| Travel and Lodging | $97,455 | 336 | 14.4% |
| Honoraria | $39,920 | 18 | 5.9% |
| Food and Beverage | $18,980 | 310 | 2.8% |
| Unspecified | $16,857 | 12 | 2.5% |
| Education | $800.37 | 8 | 0.1% |
Payments by Type
General
$658,791
827 transactions
Research
$16,857
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $385,717 | 515 | $0 (2024) |
| Sarepta Therapeutics, Inc. | $76,458 | 91 | $0 (2024) |
| PTC Therapeutics, Inc. | $53,680 | 49 | $0 (2024) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $35,726 | 37 | $0 (2023) |
| Genentech USA, Inc. | $32,835 | 23 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $21,036 | 36 | $0 (2023) |
| PFIZER INC. | $18,873 | 15 | $0 (2024) |
| AveXis | $13,863 | 22 | $0 (2019) |
| Genentech, Inc. | $9,768 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $8,150 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,440 | 49 | Genentech USA, Inc. ($17,426) |
| 2023 | $74,074 | 92 | Sarepta Therapeutics, Inc. ($28,505) |
| 2022 | $60,871 | 75 | PTC Therapeutics, Inc. ($13,765) |
| 2021 | $54,291 | 23 | Biogen, Inc. ($17,098) |
| 2020 | $56,054 | 59 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($24,896) |
| 2019 | $168,089 | 261 | Biogen, Inc. ($152,099) |
| 2018 | $138,673 | 180 | Biogen, Inc. ($126,749) |
| 2017 | $76,158 | 100 | Biogen, Inc. ($60,728) |
All Payment Transactions
839 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ITF Therapeutics LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $283.17 | General |
| 11/21/2024 | ITF Therapeutics LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| 11/14/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Consulting Fee | Cash or cash equivalent | $7,590.00 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ARGENX US, INC. | — | Consulting Fee | Cash or cash equivalent | $1,662.50 | General |
| 11/14/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Travel and Lodging | Cash or cash equivalent | $673.96 | General |
| Category: Neurology | ||||||
| 11/04/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Education | Cash or cash equivalent | $13.49 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Consulting Fee | Cash or cash equivalent | $7,085.00 | General |
| Category: Neurology | ||||||
| 10/19/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Neurology | ||||||
| 10/19/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Food and Beverage | In-kind items and services | $149.93 | General |
| Category: Neurology | ||||||
| 10/19/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Travel and Lodging | In-kind items and services | $135.63 | General |
| Category: Neurology | ||||||
| 10/19/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Food and Beverage | In-kind items and services | $135.18 | General |
| Category: Neurology | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Consulting Fee | Cash or cash equivalent | $8,508.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | In-kind items and services | $396.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | In-kind items and services | $329.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $91.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $68.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | Cash or cash equivalent | $40.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.14 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RARE NEUROLOGY CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $7,800 | 3 |
| A Phase 2 Open-Label Study to Evaluate the Safety and Tolerability of Treatment With Nusinersen Following Intravenous Onasemnogene Abeparvovec in Participants With Spinal Muscular Atrophy | Biogen, Inc. | $6,825 | 2 |
| SRP-9001-303 | Sarepta Therapeutics, Inc. | $1,902 | 6 |
| FORDADISTROGENE MOVAPARVOVEC DOMAGROZUMAB MULTI PRODUCT PF06755347 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 14 | $2,100 | $522.17 |
| 2021 | 1 | 21 | 21 | $3,150 | $744.61 |
| 2020 | 1 | 15 | 17 | $2,550 | $639.02 |
Total Patients
47
Total Services
52
Medicare Billing
$1,906
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 11 | 14 | $2,100 | $522.17 | 24.9% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 21 | 21 | $3,150 | $744.61 | 23.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 15 | 17 | $2,550 | $639.02 | 25.1% |
About Dr. John Brandsema, MD
Dr. John Brandsema, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1275889792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Brandsema, MD has received a total of $675,648 in payments from pharmaceutical and medical device companies, with $47,440 received in 2024. These payments were reported across 839 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($264,603).
As a Medicare-enrolled provider, Brandsema has provided services to 47 Medicare beneficiaries, totaling 52 services with total Medicare billing of $1,906. Data is available for 3 years (2020–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Other Specialties Neurology
- Location Philadelphia, PA
- Active Since 08/02/2012
- Last Updated 08/14/2013
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1275889792
Products in Payments
- SPINRAZA (Biological) $326,354
- ZOLGENSMA (Biological) $49,454
- Evrysdi (Drug) $36,806
- SOLIRIS (Biological) $13,524
- EXONDYS 51 (Drug) $9,621
- EMFLAZA (Drug) $8,828
- ZOLGENSMA (Drug) $7,935
- TECFIDERA (Drug) $6,133
- Exondys 51 (Drug) $5,315
- SOLIRIS (Drug) $4,950
- ADUHELM (Biological) $3,822
- Non-Covered Product (Drug) $3,422
- Emflaza (Drug) $2,351
- VILTEPSO (Drug) $1,753
- Hizentra (Biological) $1,749
- VYVGART (Drug) $1,350
- FIRDAPSE (Drug) $119.79
- NEXVIAZYME (Biological) $15.71
- AGAMREE (Drug) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Philadelphia
Adeline Vanderver, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $343,546
Neurology with Special Qualifications in Child Neurology $343,546
Susan Matesanz, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $119,195
Neurology with Special Qualifications in Child Neurology $119,195
Dr. Elizabeth Kichula, Md/Phd, MD/PHD
Neurology with Special Qualifications in Child Neurology — Payments: $101,324
Neurology with Special Qualifications in Child Neurology $101,324
Christina Szperka, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $97,640
Neurology with Special Qualifications in Child Neurology $97,640
Alexandra Kornbluh, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $87,689
Neurology with Special Qualifications in Child Neurology $87,689
Nicholas Abend, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $34,624
Neurology with Special Qualifications in Child Neurology $34,624